New report focuses on how to reduce and control hypertension

NewsGuard 100/100 Score

High blood pressure is the second leading cause of death in the United States, triggering more than one-third of heart attacks and almost half of heart failures each year even though it is relatively easy to prevent and inexpensive to treat. In a new report, A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension, the Institute of Medicine explores the question of how we can better reduce and control the condition. The report focuses on diet, physical activity, and other public health approaches, as well as discusses the need for health care providers to better diagnose and treat hypertension. The report will be released with a one-hour public briefing on Monday, Feb. 22.

DETAILS:

11 a.m. to noon EST in Room 101 of the National Academies' Keck Center, 500 Fifth St., N.W., Washington, D.C. Those who cannot attend may participate via teleconference.

Participating from the committee that wrote the report:

  • David Fleming (chair), director and health officer, Public Health -- Seattle/King County, Seattle
  • Corinne Husten, senior medical adviser, Center for Tobacco Products, Food and Drug Administration; and former vice president for policy development, Partnership for Prevention, Washington D.C.
  • Walter C. Willett, Fredrick John Stare Professor of Epidemiology and Nutrition and chair, department of nutrition, Harvard School of Public Health, Boston

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Immune dysfunction mechanism discovered in stroke and heart attack patients